I have always argued they would get bought out, why partner with someone when you can buy them for just a little bit more money.
Not too impressed with the price, should be worht 750-1000 million in my opinion. But YM didnt have much negotiation power. There is no way this company could run a successful ph III trial.
not happy with price either, sold out made $ , will move on no more BIO